Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tessalon liquid cough capsules pose risk for young children: FDA
Tessalon, an FDA approved drug to treat symptomatic relief of cough in patients older than 10, may attract younger children as the drug has a candy-like appearance –
Tessalon, an FDA approved drug to treat symptomatic relief of cough in patients older than 10, may attract younger children as the drug has a candy-like appearance –
Crolibulin is a vascular disruption and apoptosis inducing agent, which demonstrated potent anti-tumor activity in both preclinical and early clinical studies. The trial is designed to evaluate the
The study enrolled 31 subjects diagnosed with impaired glucose tolerance (IGT), with a with a mean age of 52 years and a body mass index of 33. The
MitoCare will begin in January 2011 and will be conducted by a 16 partner consortium led by Trophos. MitoCare will evaluate the safety and efficacy of TRO40303 in
Watson Pharmaceuticals has confirmed that Watson Laboratories has filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market Hydromorphone
The agreement is designed to enable substantial advances in existing manufacturing process for the benefit of both partners. bluebird bio president and CEO Nick Leschly said that Genethon
Skinvisible concluded the development phase for the hemorrhoid formulation using Skinvisible’s technology Invisicare, a patented polymer delivery system for topical dermatology and consumer goods products. The product has
The current collaboration follows previous agreements, initially started in 2004, and extends the partnership between both the two parties for three years. The tie up will provide support
The clinical study is being directed by Steffen Weikert, assistant director of the clinic for Urology at the Charite of Berlin. The primary goal of this study is
SurModics said that Maharaj will also serve as a member of SurModics’ board of directors. Maharaj, who most recently served as president and CEO of Arizant, will replace